These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21968275)

  • 1. Marinobufagenin and cyclic strain may activate endothelial NADPH oxidase, contributing to the adverse impact of salty diets on vascular and cerebral health.
    McCarty MF
    Med Hypotheses; 2012 Feb; 78(2):191-6. PubMed ID: 21968275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium.
    McCarty MF
    Med Hypotheses; 2004; 62(6):993-1002. PubMed ID: 15142663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium.
    McCarty MF
    Med Hypotheses; 2005; 64(4):854-63. PubMed ID: 15694707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marinobufagenin may mediate the adverse impact of salty diets on renal calcium retention by impairing the efficiency of renal tubular sodium-calcium exchange.
    McCarty MF
    Med Hypotheses; 2005; 64(5):1027-9. PubMed ID: 15780505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.
    Fedorova OV; Kashkin VA; Zakharova IO; Lakatta EG; Bagrov AY
    J Hypertens; 2012 Sep; 30(9):1817-26. PubMed ID: 22796708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin.
    Grigorova YN; Juhasz O; Zernetkina V; Fishbein KW; Lakatta EG; Fedorova OV; Bagrov AY
    Am J Hypertens; 2016 May; 29(5):641-6. PubMed ID: 26350300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.
    Grigorova YN; Juhasz O; Long JM; Zernetkina VI; Hall ML; Wei W; Morrell CH; Petrashevskaya N; Morrow A; LaNasa KH; Bagrov AY; Rapp PR; Lakatta EG; Fedorova OV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats.
    Grigorova YN; Wei W; Petrashevskaya N; Zernetkina V; Juhasz O; Fenner R; Gilbert C; Lakatta EG; Shapiro JI; Bagrov AY; Fedorova OV
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30326586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.
    Fedorova OV; Lakatta EG; Bagrov AY; Melander O
    J Hypertens; 2015 Mar; 33(3):534-41; discussion 541. PubMed ID: 25479026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
    Fedorova OV; Emelianov IV; Bagrov KA; Grigorova YN; Wei W; Juhasz O; Frolova EV; Marshall CA; Lakatta EG; Konradi AO; Bagrov AY
    J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study.
    Strauss-Kruger M; Kruger R; Smith W; Gafane-Matemane LF; Mokwatsi G; Wei W; Fedorova OV; Schutte AE
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells.
    Periyasamy SM; Liu J; Tanta F; Kabak B; Wakefield B; Malhotra D; Kennedy DJ; Nadoor A; Fedorova OV; Gunning W; Xie Z; Bagrov AY; Shapiro JI
    Kidney Int; 2005 May; 67(5):1868-77. PubMed ID: 15840034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
    Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.